Biohit Oyj - Changes board/management/auditors

Lea Paloheimo appointed Biohit Oyj’s R&D and production director

Biohit Oyj Changes board/management/ auditors May 4, 2017 at 10:00 a.m. local
time (EEST) 


Lea Paloheimo, PhD (clinical biochemistry), has been appointed Biohit Oyj’s R&D
and production director. Lea Paloheimo has been a member of the Biohit Oyj’s
management team since 2006. 

CEO Semi Korpela, Biohit Oyj: ‘Lea Paloheimo has over fifteen years of
experience in various positions in Biohit Oyj.’ 


Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com



Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com